Search results
Results from the WOW.Com Content Network
Complex regional pain syndrome is uncommon, and its cause is not clearly understood. CRPS typically develops after an injury, surgery, heart attack, or stroke. [8] [12] Investigators estimate that 2–5% of those with peripheral nerve injury, [13] and 13–70% of those with hemiplegia (paralysis of one side of the body) [14] will develop CRPS.
Patients and their diseases are profiled in order to identify the most effective treatment for their specific case. Targeted therapy or molecularly targeted therapy is one of the major modalities of medical treatment (pharmacotherapy) for cancer, [1] others being hormonal therapy and cytotoxic chemotherapy.
Unlike transcutaneous electrical nerve stimulation (TENS), another form of transcutaneous electrical stimulation for pain relief, in which the analgesic benefit has only been seen during and sometimes in the immediate hours after treatment, treatment with scrambler therapy has been shown to produce long lasting pain relief. [6]
Cancer. Cachexia/wasting syndrome. Causalgia. Chronic inflammatory demyelinating polyneuropathy. Chronic pain. Crohn’s disease. CRPS (complex regional pain syndrome Type II) Dystonia. Ehlers ...
Chronic systemic inflammation is the result of release of pro-inflammatory cytokines from immune-related cells and the chronic activation of the innate immune system.It can contribute to the development or progression of certain conditions such as cardiovascular disease, cancer, diabetes mellitus, chronic kidney disease, non-alcoholic fatty liver disease, autoimmune and neurodegenerative ...
It has been used in the treatment of pain related to diabetic neuropathy, muscle sprains, temporomandibular joint disorders, type I complex regional pain syndrome as well as the healing of wounds such as diabetic ulcers. [14] [15] This electroanalgesic modality was originally recommended as an alternative to TENS for dental analgesia.
Cancer treatments are a wide range of treatments available for the many different types of cancer, with each cancer type needing its own specific treatment. [1] Treatments can include surgery, chemotherapy, radiation therapy, hormonal therapy, targeted therapy including small-molecule drugs or monoclonal antibodies, [2] and PARP inhibitors such as olaparib. [3]
A review of several treatments found that azathioprine, interferon alpha and methotrexate were not effective. [41] Cyclophosphamide and rituximab seem to have some response. Mycophenolate mofetil may be of use in milder cases. Immunoglobulin and steroids are the first line choices for treatment. [citation needed]